Free Trial

ADMA Biologics Q2 2023 Earnings Report

ADMA Biologics logo
$18.01 -1.44 (-7.40%)
As of 04/4/2025 04:00 PM Eastern

ADMA Biologics EPS Results

Actual EPS
-$0.02
Consensus EPS
-$0.02
Beat/Miss
Met Expectations
One Year Ago EPS
-$0.07

ADMA Biologics Revenue Results

Actual Revenue
$60.12 million
Expected Revenue
$55.45 million
Beat/Miss
Beat by +$4.67 million
YoY Revenue Growth
N/A

ADMA Biologics Announcement Details

Quarter
Q2 2023
Time
After Market Closes

Conference Call Resources

Conference Call Audio

Remove Ads

ADMA Biologics Earnings Headlines

Your Retirement Is Caught in the Crossfire
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
See More ADMA Biologics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ADMA Biologics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ADMA Biologics and other key companies, straight to your email.

About ADMA Biologics

ADMA Biologics (NASDAQ:ADMA), a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

View ADMA Biologics Profile

More Earnings Resources from MarketBeat